Technology

Amphastar Pharmaceuticals

$18.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-1.52%) Today
$0.00 (0.00%) As of 12:00 PM UTC after-hours

Why Robinhood?

You can buy or sell AMPH and other stocks, options, and ETFs commission-free!

About AMPH

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA. The listed name for AMPH is Amphastar Pharmaceuticals, Inc. Common Stock.

CEO
Yong Feng Zhang
Employees
2,027
Headquarters
Rancho Cucamonga, California
Founded
1996
Market Cap
890.76M
Price-Earnings Ratio
142.16
Dividend Yield
—
Average Volume
179.13K
High Today
$19.27
Low Today
$18.52
Open Price
$18.77
Volume
144.89K
52 Week High
$22.69
52 Week Low
$12.33

Collections

AMPH Earnings

$0.00
$0.06
$0.11
$0.17
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

BMAR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure